The Ketamine Endgame. Silo Pharmaceutical (SILO).

James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference. Dr....

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects FT. LAUDERDALE, FL /...

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Rick Doblin, Recently Visited one of Psycheceutical's Labs. Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes...

Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.

We Liked it at $3.50, we Love it at $2.25. Down but not out. Now trading below the cash they have in the bank, this...

Revive Therapeutics (RVVTF) Advancing MDMA Thermal Patch.

Two News Reports Related to Revives Upcoming Microneedle Patch Technology While we are still laser focused on Revive having a successful meeting with the FDA...
Silo Pharma, Psychedelic Stock Review, Roland Rick Perry

SILO Pharma (SILO) Gains 53%

For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun. Silo Pharma Gains 53% Intraday on Patent (Ketamine) Related News Our opinion...

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion) and there...

Adding ATAI (ATAI) to 2024 Watch List. Doubling Down at $1.80, After Anti Depression...

Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm. Atai was founded in 2018 and went public in June...

Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!

And We Weren't Watching! It was Friday after all, and the last day of the year, and we were celebrating our 78% gain in Ardelyx...
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE...

Latest article

Biotech Stock Review, Nutriband

Report III: A Deeper Dive Into the Nutriband’s (NTRB) $200 Million Revenue Estimate.

Look at the Basic Math and Decide for Yourself. Click Here to Open News coverage and reporting client. See report for full disclosure and disclaimer details. Standard...

Report II: Updating Coverage on Nutriband (NTRB) $7.77.

Hmm. The number 777 is commonly interpreted as a sign of spiritual alignment, good fortune. Let's hope these revenue forecasts are on the money!...
Pan Global Resources, Institutional Gold Analyst

Pan Global Resources (PGZ) Investor Presentation.

Pan Global Resources (PGZ, PGZFF) a Proven Ground Exploration company, will doing a non-deal roadshow in the Palm Beach Area tonight. We'll attend and...